drug: mazindol |
|
|
*| Clinical class | anorexiant, antiobesity, psychostimulant (amphetamine-like) |
| Action | central nervous system stimulant |
| Chemical class | heterocyclic |
| CSA schedule | IV |
| DEA number | 1605 |
| Routes of administration | oral |
| Associated with (substance-related)
|
disorders: disorders |
| Availability | prescription |
U.S. Preparations:
Sanorex, Mazanor (Sandoz) FDA approved for treatment of : muscular dystrophy (orphan drug)
Preparations Outside U.S.:
Degonan, Teronac
*Molecule graphic courtesy of Steve Chapman